protein

CLUSTERIN

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CLUSTERIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

298Connections
1Hypotheses
1Analyses
50Outgoing
50Incoming
4Experiments

Summary

CLUSTERIN is a protein involved in neurodegeneration research. Key relationships include: associated with, regulates, activates. Associated with ALS, Aging, Als. Connected to 115 entities in the SciDEX knowledge graph.

View on Wiki →

🔬 Protein Info
Gene SymbolCLU
Full NameClusterin
AliasesPage for CLU Gene
Chromosome8p21.1
Protein FamilyApolipoprotein / extracellular chaperone
FunctionIt binds to non-native, misfolded, or aggregation-prone proteins and maintains them in a soluble state suitable for subsequent processing (Wyatt et al., 2009)
Primary ExpressionSecreted (sCLU), cytoplasmic/nuclear (nCLU/iCLU)
Molecular Weight~75-80 kDa (heterodimer)
Amino Acids522 aa
Exons9
PathwaysApoptosis, Complement, Immune Response, Mitophagy
UniProt IDP10909
NCBI Gene ID1115
Ensembl IDENSG00000120885
OMIM185551
GeneCardsCLU
Human Protein AtlasCLU
Associated DiseasesALS, Aging, Alzheimer, Alzheimer Disease, Alzheimer'S Disease
InteractionsLC3, C1Q, BACE1, PI3K, AKT, BAX
KG Connections292 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: CLUSTERIN — AlphaFold P10909 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

Clusterin (ApoJ) - AD Biomarker

biomarker · 1403 words

neuroinflammation

mechanism · 5462 words

Alzheimer's Disease

disease · 5265 words

Astrocyte Reactivity Mechanism

mechanism · 5036 words

TREM2 Microglial Signaling Pathway in Neurodegeneration

mechanism · 4613 words

Synaptic Vesicle Trafficking in Parkinson's Disease

mechanism · 4417 words

Pathway Diagram

graph TD
    CLUSTERIN["<b>CLUSTERIN</b>"]
    Cancer{"Cancer"}
    CLUSTERIN -->|"regulates"| Cancer
    Neurodegeneration{"Neurodegeneration"}
    CLUSTERIN -->|"associated with"| Neurodegeneration
    Alzheimer{"Alzheimer"}
    CLUSTERIN -->|"associated with"| Alzheimer
    CLUSTERIN -->|"activates"| Alzheimer
    Als{"Als"}
    CLUSTERIN -->|"activates"| Als
    CLUSTERIN -->|"activates"| Cancer
    CLUSTERIN -->|"expressed in"| Alzheimer
    Tumor{"Tumor"}
    CLUSTERIN -->|"expressed in"| Tumor
    Senescence{"Senescence"}
    CLUSTERIN -->|"expressed in"| Senescence
    ALS{"ALS"}
    CLUSTERIN -->|"causes"| ALS
    Parkinson{"Parkinson"}
    CLUSTERIN -->|"causes"| Parkinson
    LC3["LC3"]
    CLUSTERIN -->|"activates"| LC3
    CLU["CLU"]
    CLU -->|"regulates"| CLUSTERIN
    PPARGC1A["PPARGC1A"]
    PPARGC1A -->|"regulates"| CLUSTERIN
    BAX["BAX"]
    BAX -->|"activates"| CLUSTERIN
    C1S["C1S"]
    C1S -->|"regulates"| CLUSTERIN
    PPARG["PPARG"]
    PPARG -->|"regulates"| CLUSTERIN
    CLU -->|"activates"| CLUSTERIN
    CLU -->|"therapeutic target"| CLUSTERIN
    BAX -->|"regulates"| CLUSTERIN
    C1Q["C1Q"]
    C1Q -->|"activates"| CLUSTERIN
    RS6656401["RS6656401"]
    RS6656401 -->|"associated with"| CLUSTERIN
    RS3919533["RS3919533"]
    RS3919533 -->|"associated with"| CLUSTERIN
    BIN1["BIN1"]
    BIN1 -->|"activates"| CLUSTERIN
    style CLUSTERIN fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (203)

TargetRelationTypeStr
Alzheimer's disease pathologyinvolved_inmechanism0.85
Plasma complement protein levelsbiomarker_forbiomarker0.80
Immune dysregulationinvolved_inprocess0.80
Alzheimerassociated_withdisease0.75
Alsactivatesdisease0.75

Incoming (95)

SourceRelationTypeStr
BACE1regulates_expressiongene0.90
CLUregulatesgene0.70
APOPTOSISactivatesgene0.70
CANCERactivatesentity0.60
PPARGC1Aregulatesgene0.60

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Magnetosonic-Triggered Transferrin Receptor Clustering 0.470 neurodegeneration Blood-brain barrier transport mechanisms

Mentioning Analyses (1)

Scientific analyses that reference this entity

Does clusterin exacerbate or protect against neuronal death in neurodegeneration

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.548

Experiments (4)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Therapy validation Parkinson's Disease 0.400 0.50 mouse proposed $280,000
AAV Serotype Comparison for LRRK2 Knockdown in PD validation Parkinson's Disease 0.400 0.50 mouse proposed $280,000
s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice with engin falsification Neuroinflammation 0.400 0.50 mouse proposed $200,000
s:** - Compare uptake with/without magnetic particles using tight junc falsification Neurodegeneration 0.400 0.50 cell_line proposed $120,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease. [PMID:40425446] Sehlin D, Hultqvist G, Michno W, Aguilar J Prev Alzheimers Dis 2025 1
Effect of ferroptosis on chronic cerebral hypoperfusion in vascular dementia. [PMID:37709116] Fu P, Chen Y, Wu M, Bao B, Yin X, Chen Z Exp Neurol 2023 1
On Iron Metabolism and Its Regulation. [PMID:33925597] Vogt AS, Arsiwala T, Mohsen M, Vogel M, Int J Mol Sci 2021 1
Transferrin Receptor Is a Specific Ferroptosis Marker. [PMID:32160546] Feng H, Schorpp K, Jin J, Yozwiak CE, Ho Cell Rep 2020 1
Transferrin and transferrin receptors update. [PMID:29969719] Kawabata H Free Radic Biol Med 2019 1
A proimmunotoxin nanodrug targeting AIDS-associated non-Hodgkin lymphoma. [PMID:41592623] Chen S, Qi T, Peng H, Kimura E, Zhang X J Control Release 2026 0
Time- and dose-dependent effects of bacterial infection on iron metabolism, infl [PMID:41619877] Lu Y, Zhang Y, Niu C Comp Biochem Physiol A Mol Int 2026 0
Ayanin combats against barium sulphate nanoparticles induced hepatotoxicity via [PMID:41666660] Zhu D, Lu Y, Jamil S, Ashfaq H, Al-Emam J Trace Elem Med Biol 2026 0
Role of iron and TfR1 in the application of high‑dose ascorbate against pancreat [PMID:41789665] Piotrowsky A, Leischner C, Schmieder H, Oncol Rep 2026 0
Brain and Liver Dual-Targeting Oridonin Nanoparticles to Enhance Aβ Clearance fo [PMID:41944296] Gong W, Hui W, Qiao S, Ji Q, Liu M et al Adv Sci (Weinh) 2026 0
Cerebrospinal Fluid from Restless Legs Syndrome Patients Reduces Iron Uptake in [PMID:41947413] Palsa K, Sahu AP, Rye DB, Trotti LM, Elc Ann Neurol 2026 0
Pulmonary neuroendocrine cell-derived exosomes regulate iron homeostasis and oxi [PMID:41950316] Thakur A, Zhang K, Chen J, Mei S, Chen J Sci Adv 2026 0
O-GlcNAc Modification Orchestrates HUWE1-Mediated Ubiquitination of TfR1 to Regu [PMID:41962599] Zhang H, Li M, Zhang J, Sun Q, Jin X et Free Radic Biol Med 2026 0
Protective Role of Polydatin Against Vancomycin-Induced Lung Toxicity via Oxidat [PMID:41963266] Aygörmez S, Küçükler S, Çomaklı S, Şimşe J Appl Toxicol 2026 0
Yangxin granules exert cardioprotective effects against acute myocardial infarct [PMID:41868900] Huo G, Zhou Y, Wu Z, Sun S, Zhu G, Cheng American journal of translatio 2026 0
Conformational dynamics study of TfR1 upon transferrin binding via NMA and MD si [PMID:41921418] Zemmouche M, Falque G, Cadet F, Gardebie Journal of molecular graphics 2026 0
[Effects of acupuncture on ferroptosis and ferritinophagy in cerebral ischemia-r [PMID:41839581] Wang YF, Dong YS Zhen ci yan jiu = Acupuncture 2026 0
The therapeutic potential of Piezo1 channel-mediated ferroptosis and its inhibit [PMID:41854751] Nan K, Zhang L, Zhao Y, Yin S, Peng Y, H Apoptosis : an international j 2026 0
The Role of Artemisinin and its Derivatives in Cancer Therapy via Ferroptosis: A [PMID:41833023] Osmanlioglu Dag SR, Tatli Cankaya II, Oz Anti-cancer agents in medicina 2026 0
Raccoon eyes. [PMID:35789012] Ning J Journal of paediatrics and chi 2023 0